Gestational trophoblastic tumours: an update for 2014

Fieke E M Froeling1, Michael J Seckl

  • 1Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College Healthcare NHS Trust and Imperial College London, Fulham Palace Road, London, W6 8RF, UK.

Current Oncology Reports
|October 17, 2014
PubMed
Summary

Gestational trophoblastic disease (GTD) encompasses premalignant and malignant conditions. Effective treatments and early detection via human chorionic gonadotrophin markers lead to over 98% survival rates for GTD.

Related Concept Videos